Dr. Raeman is an Associate Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a core member of Pittsburgh Liver Research Center. Dr. Raeman earned his MS from Clemson University, PhD from the University of Georgia and completed his postdoctoral training at Emory University School of Medicine. Dr. Raeman specializes in delineating the cellular and molecular mechanisms of chronic liver diseases, specifically focusing on the role of gut-liver-immune axis in chronic liver disease progression. The current research in Dr.

Dr. Lisa Deng is the Director of Liver Clinic at the San Francisco VA Healthcare System and Assistant Clinical Professor of Medicine at University of California, San Francisco. Dr. Deng's academic mission is to improve outcomes for patients with advanced liver disease through integration of geriatric and palliative care principles into hepatology care. She completed medical school, Internal Medicine residency, Gastroenterology and Transplant Hepatology fellowships at the University of California, San Francisco.

Dr. Tombazzi is an Assistant Professor of Medicine at Vanderbilt University Medical Center in the Divisions of Gastroenterology, Hepatology and Nutrition as well as Palliative Care Medicine. He completed medical school at University of Tennessee Health Science Center-Memphis, internal medicine residency at VUMC and subsequently completed Hospice and Palliative Medicine Fellowship, Gastroenterology, and Transplant Hepatology fellowships at VUMC.

Vincent Lo Re, MD, MSCE is Professor of Medicine in the Division of Infectious Diseases of the Robert Wood Johnson Medical School of Rutgers University and Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science within the Rutgers Institute for Health. Dr. Lo Re leads an NIH-funded research program focused on pharmacoepidemiology research.

Dr. Jonathan Sexton is faculty in the Department of Internal Medicine in the Division of Gastroenterology and Hepatology, and the College of Pharmacy, Medicinal Chemistry at the University of Michigan. Dr. Sexton is a translational scientist with expertise in artificial intelligence-enhanced drug discovery and development. His research focuses on advancing lead compounds toward clinical applications in various therapeutic areas, particularly in liver and gastrointestinal diseases.

Dr. Amar Bansal is a nephrologist and palliative care physician at the University of Pittsburgh. He is the Associate Program Director for the nephrology training program. He has an interest in serious illness communication. He is the course director for "GiTalk," a communication workshop based on VitalTalk designed for GI providers. It is held annually for GI fellows and APP's at UPMC/Pitt.

Dr. Gedallovich is a gastroenterologist and transplant hepatologist, practicing as a Clinical Assistant Professor at Stanford University. Prior to this, she completed Gastroenterology and Transplant Hepatology fellowships at Stanford University and Hospice & Palliative Medicine fellowship at the University of California San Francisco. She is passionate about the integration of palliative medicine into the care of patients with advanced liver disease.

Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Transplant Hepatologist at the Northwell Health Center for Liver Disease and Transplantation with a focus on Palliative Care and Care Coordination. I completed my Hospice & Palliative Medicine, Gastroenterology, and Transplant Hepatology training at Mount Sinai Hospital.

Cristal Brown, MD, MHS is a transplant hepatologist and Assistant Professor of Medicine at the University of Texas at Austin Dell Medical School. As a physician-scientist, Dr. Brown focuses on interventions to help eliminate health disparities throughout the trajectory of end-stage liver disease.

Dr. Jessica Hartman is an Associate Professor in the Department of Biochemistry and Molecular Biology and the Department of Regenerative Medicine at the Medical University of South Carolina. Dr. Hartman completed her Ph.D. with the support of a NSF GRFP fellowship at the University of Arkansas for Medical Sciences in the lab of Dr. Grover Miller studying enzyme kinetics of substrate oxidation by cytochrome P450 2E1 (CYP2E1). She then went on to do a NIEHS F32-supported postdoctoral fellowship with Dr.